Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Red Blood Cell Survival in Sickle Cell Disease

Phase 1

Completed

Conditions: Sickle Cell Disease

Interventions: Drug: Biotin Labeled Red Blood Cells
Device: INTERCEPT Blood System

First Posted Date: 2020-06-11

Last Posted Date: 2025-06-08

Lead Sponsor: Marianne Yee

Target Recruit Count: 22

Registration Number: NCT04426591

Locations: 🇺🇸
Hughes Spalding Children's Hospital, Atlanta, Georgia, United States
🇺🇸
Childrens Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸
Grady Health System, Atlanta, Georgia, United States

Oral Anti Diabetic Agents in the Hospital

Phase 4

Recruiting

Conditions: Diabetes Mellitus

Interventions: Drug: Oral Anti-diabetes Drugs alone
Drug: Basal bolus insulin
Drug: Supplemental insulin
Device: Continuous glucose monitoring (CGM)

First Posted Date: 2020-06-04

Last Posted Date: 2024-12-12

Lead Sponsor: Emory University

Target Recruit Count: 260

Registration Number: NCT04416269

Locations: 🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States

Distress in the Pediatric Oncology Setting: Intervention Versus Natural Adaptation

Not Applicable

Completed

Conditions: Pediatric Cancer

Interventions: Other: My Special Aflac Duck (MSAD)
Behavioral: Standard of care control

First Posted Date: 2020-06-01

Last Posted Date: 2024-02-20

Lead Sponsor: Emory University

Target Recruit Count: 160

Registration Number: NCT04409301

Locations: 🇺🇸
Children's of Alabama, Birmingham, Alabama, United States
🇺🇸
Connecticut Children's Medical Center, Hartford, Connecticut, United States
🇺🇸
Comer Children's Hospital, Chicago, Illinois, United States

and more 5 locations

Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)

Recruiting

Conditions: Phenylketonurias

Interventions: Drug: Palynziq

First Posted Date: 2020-05-27

Last Posted Date: 2024-11-22

Lead Sponsor: Emory University

Target Recruit Count: 45

Registration Number: NCT04404530

Locations: 🇺🇸
Emory University Hospital Georgia Clinical Research Center, Atlanta, Georgia, United States
🇺🇸
The Emory Clinic, Atlanta, Georgia, United States

Pharmacy-based Pre-exposure Prophylaxis

Not Applicable

Completed

Conditions: Human Immunodeficiency Virus

Interventions: Behavioral: Pharmacy Delivered PrEP Intervention

First Posted Date: 2020-05-19

Last Posted Date: 2025-05-28

Lead Sponsor: Emory University

Target Recruit Count: 49

Registration Number: NCT04393935

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States

Equality in Caregiving: Facilitating Caregiver Mastery Among LGBT Caregivers of PLWD

Completed

Conditions: Caregiver Burnout
Dementia

Interventions: Behavioral: Savvy Caregiver Program via Remote Learning
Behavioral: Focus group

First Posted Date: 2020-05-19

Last Posted Date: 2023-03-10

Lead Sponsor: Emory University

Target Recruit Count: 10

Registration Number: NCT04394260

Locations: 🇺🇸
Emory Goizueta Alzheimer's Disease Research Center (ADRC), Atlanta, Georgia, United States

Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma

Phase 2

Active, not recruiting

Conditions: Kidney Cancer
Stage III Renal Cell Cancer AJCC v8
Stage IV Renal Cell Cancer AJCC v8

Interventions: Drug: Lenvatinib
Drug: Lenvatinib Mesylate
Biological: Pembrolizumab
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2020-05-19

Last Posted Date: 2025-02-26

Lead Sponsor: Emory University

Target Recruit Count: 18

Registration Number: NCT04393350

Locations: 🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

iTransition Development

Not Applicable

Completed

Conditions: Human Immunodeficiency Virus
HIV Seropositivity

Interventions: Behavioral: iTransition

First Posted Date: 2020-05-12

Last Posted Date: 2024-08-06

Lead Sponsor: Emory University

Target Recruit Count: 52

Registration Number: NCT04383223

Locations: 🇺🇸
Grady Hospital, Atlanta, Georgia, United States
🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸
University of Pennsylvania Health System - HUP and Presby infectious disease clinics, Philadelphia, Pennsylvania, United States

Biomechanical and Neural Mechanisms of Post-stroke Gait Training

Not Applicable

Recruiting

Conditions: Stroke

Interventions: Device: Functional electrical stimulation (FES)
Other: Fast treadmill walking

First Posted Date: 2020-05-08

Last Posted Date: 2025-01-23

Lead Sponsor: Emory University

Target Recruit Count: 60

Registration Number: NCT04380454

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

Healthy Homes/Healthy Families (HH/HF) Intervention in 2-1-1 Callers

Not Applicable

Completed

Conditions: Weight Change, Body

Interventions: Behavioral: Control
Behavioral: Health Homes/Healthy Families (HH/HF) Intervention

First Posted Date: 2020-05-04

Last Posted Date: 2024-02-12

Lead Sponsor: Emory University

Target Recruit Count: 512

Registration Number: NCT04373434

Locations: 🇺🇸
Emory University, Rollins School of Public Health, Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy